Skip to content

Journal article

Source notes

EFSA Journal · 2013

Bibliographic details

Source record

EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS)

Scientific Opinion on the re‐evaluation of aspartame (E 951) as a food additive

Wiley. 11(12).

Study type
Regulatory scientific opinion and risk assessment
Review basis
Full text reviewed

Aspartame safety depends on exposure, not simply on whether the ingredient is present. In its 2013 assessment, the panel retained an acceptable daily intake of 40 milligrams per kilogram of body weight. This represents a lifetime daily exposure judged to pose no appreciable health risk, not an amount to aim for. Using reported food levels, the highest estimate for high-consuming groups was 36 milligrams per kilogram daily, in toddlers aged 12–35 months. This was a conservative estimate at the 95th percentile, not a measured dose received by every child.

The assessment considered what happens after digestion, when aspartame breaks into phenylalanine, aspartic acid, and methanol. The presence of these breakdown products alone does not establish harm; their amounts and effects matter. There is an important exception: the intake limit does not apply to people with phenylketonuria, or PKU, an inherited condition that impairs phenylalanine handling and requires strict dietary management.

How Does This Show Up in Real Life?

For someone comparing sweetened foods, this separates an ingredient-safety question from a nutrition question. A conclusion about exposure does not show that an aspartame-containing drink improves health or that everyone should consume it. The assessment considers intake across foods, not a single product in isolation. Body weight and the amount of sweetener in each food matter, so the limit cannot be converted into a universal number of drinks without product information. The PKU exception also changes how reassurance should be read: a conclusion for the general population is not automatically guidance for someone with a specific metabolic condition. This document supports understanding the panel's reasoning at the time. It does not provide a personalized consumption plan or test the overall quality of a diet.

The evidence included older animal studies that predated modern testing standards; the panel assessed whether their design and reporting were adequate. Exposure calculations also depended on short dietary surveys, food reporting, and assumptions about ingredient levels. The panel judged these assumptions generally more likely to overestimate exposure, but they do not remove uncertainty about any individual's actual intake.

Why We Cite It

Alpekin gains an example of how to explain the difference between a concerning laboratory finding and a risk assessment for human exposure. It supports educational material that makes the reasoning visible: what was tested, which biological pathway matters, and how uncertainty affects interpretation, rather than treating every alarming result as equivalent evidence.

Take the boundaries of this assessment as seriously as its reassurance. It records a conclusion reached from the evidence evaluated in 2013, not an account of all later research. Its strongest use is explaining safety reasoning, not endorsing a product or an unrestricted intake.

Where this source appears

Pages citing this source

2 pages · 1 article · 1 wiki

Articles

Wikis